Table 1 Demographic data and clinical characteristics of the study group

Age (years)

 Mean ± SD

51.400 ± 12.838

 Range

(23–77)

Gender (N (%))

 Male

25 (50%)

 Female

25 (50%)

Co-morbidities (N (%))

 DM

13 (26%)

 HTN

28 (56%)

 ISHD

4 (8%)

 Others

2 (4%)

Child score calculation (N (%))

 A5

42 (84%)

 A6

8 (16%)

Liver by PAUS (N (%))

 Normal hepatic echopattern

22 (44%)

 Chronic parenchymatous liver disease

17 (34%)

 Coarse echopattern

11 (22%)

Spleen by PAUS

 Enlarged

7 (14%)

 Normal

43 (86%)

Ascites by PAUS

 Yes

2 (4%)

 No

48 (96%)

Baseline laboratory investigations (week 0), mean ± SD (range)

Alpha feto protein (IU/l)

3.459 ± 3.948 (0.54–26)

Serum Creatinine (mg/dl)

7.345 ± 1.981 (3.6–12.75)

PCR for HCV (IU/ml) week 0

2,629,176.880 ± 4,598,628.996 (10,601–23,102,362)